Martins Silvia S, Sampson Laura, Cerdá Magdalena, Galea Sandro
Am J Public Health. 2015 Nov;105(11):2373. doi: 10.2105/AJPH.2015.302843a.
Drug overdose is an important, yet an inadequately understood, public health problem. Global attention to unintentional drug overdose has been limited by comparison with the scope of the problem. There has been a substantial increase in drug overdose incidence and prevalence in several countries worldwide over the past decade, contributing to both increased costs and mortality.
The aim of this study was to systematically synthesize the peer-reviewed literature to document the global epidemiological profile of unintentional drug overdoses and the prevalence, time trends, mortality rates, and correlates of drug overdoses. We searched different combinations of Medical Subject Headings (MeSH) terms in PubMed for articles published from 1980 until July 2013, and we organized these results in tabular spreadsheets and compared them. We restricted the search to English-language articles that deal with unintentional overdose, focusing on 1 or more of the following key constructs: prevalence, time trends, mortality rates, and correlates. The term "overdose" as a MeSH major topic yielded 1076 publications. In addition, we searched the following combinations of nonmajor MeSH terms: "street drugs" and "overdose" yielded 180, "death" and "overdose" yielded 114, and "poisoning" and "drug users" yielded 17. There was some overlap among the searches. Based on the search and inclusion and exclusion criteria, we selected a total of 169 relevant articles for this article based on a close review of abstracts.
We found wide variability in lifetime prevalence of experiencing a nonfatal overdose or witnessing an overdose, and in mortality rates attributable to overdose. Lifetime prevalence of witnessed overdose among drug users (n = 17 samples) ranged from 50% to 96%, with a mean of 73.3%, a median of 70%, and a standard deviation of 14.1%. Lifetime prevalence of drug users personally experiencing a nonfatal overdose (n = 27 samples), ranged from 16.6% to 68.0% with a mean of 45.4%, a median of 47%, and a standard deviation of 14.4%. Population-based crude overdose mortality rates (n = 28 samples) ranged from 0.04 to 46.6 per 100 000 person-years. This range is likely attributable to the diversity in regions, time periods, and samples. Most studies on longitudinal trends of overdose death rates or overdose-related hospitalization rates showed increases in overdose death rates and in overdose-related hospitalization rates across time, which have led to peaks in these rates at the present time. An overall trend of increasing deaths from prescription opioid use and decreasing deaths from illicit drug use in the past several years has been noted across most of the literature. With the increase in prescription opioid overdose deaths, drug overdose is not just an urban problem: rural areas have seen an important increase in overdose deaths. Lastly, cocaine, prescription opioids, and heroin are the drugs most commonly associated with unintentional drug overdoses worldwide and the demographic and psychiatric correlates associated with unintentional drug overdoses are similar globally.
There is a need to invest in research to understand the distinct determinants of prescription drug overdose worldwide. Several other countries need to collect in a systematic and continuous fashion such data on sales of prescription opioids and other prescription drugs, nonmedical use of prescription drugs, and hospitalization secondary to overdoses on prescription drugs. The sparse evidence on the environmental determinants of overdose suggests a need for research that will inform the types of environmental interventions we can use to prevent drug overdose. Methodological issues for future studies include enhancing data collection methods on unintentional fatal and nonfatal overdoses, and collecting more detailed information on drug use history, source of drug use (for prescription drugs), and demographic and psychiatric history characteristics of the individual who overdosed.
药物过量是一个重要但尚未得到充分理解的公共卫生问题。与该问题的范围相比,全球对无意药物过量的关注有限。在过去十年中,全球多个国家的药物过量发病率和患病率大幅上升,导致成本增加和死亡率上升。
本研究的目的是系统地综合同行评审文献,以记录无意药物过量的全球流行病学概况以及药物过量的患病率、时间趋势、死亡率和相关因素。我们在PubMed中搜索了医学主题词(MeSH)术语的不同组合,以查找1980年至2013年7月发表的文章,并将这些结果整理成表格电子表格并进行比较。我们将搜索限制在涉及无意过量用药且关注以下一个或多个关键结构的英文文章:患病率、时间趋势、死亡率和相关因素。作为MeSH主要主题的“过量用药”一词产生了1076篇出版物此外,我们搜索了以下非主要MeSH术语的组合:“街头毒品”和“过量用药”产生了180篇,“死亡”和“过量用药”产生了114篇,“中毒”和“吸毒者”产生了17篇。搜索之间存在一些重叠。根据搜索以及纳入和排除标准基于对摘要的仔细审查,我们为本文章共选择了169篇相关文章。
我们发现经历非致命过量用药或目睹过量用药的终生患病率以及过量用药导致的死亡率存在很大差异。吸毒者中目睹过量用药的终生患病率(n = 17个样本)范围为50%至96%,平均为73.3%,中位数为70%,标准差为14.1%。吸毒者个人经历非致命过量用药的终生患病率(n = 27个样本)范围为16.6%至68.0%,平均为45.4%,中位数为47%,标准差为14.4%。基于人群的粗过量用药死亡率(n = 28个样本)范围为每10万人年0.04至46.6。这个范围可能归因于地区、时间段和样本的多样性。大多数关于过量用药死亡率或与过量用药相关的住院率的纵向趋势的研究表明,随着时间的推移,过量用药死亡率和与过量用药相关的住院率都有所增加,目前这些比率已达到峰值。在大多数文献中都注意到,在过去几年中,处方阿片类药物使用导致的死亡总体呈上升趋势,非法药物使用导致的死亡呈下降趋势。随着处方阿片类药物过量死亡人数的增加,药物过量不仅仅是一个城市问题:农村地区的过量死亡人数也有显著增加。最后,可卡因、处方阿片类药物和海洛因是全球与无意药物过量最常相关的药物,并且全球与无意药物过量相关的人口统计学和精神病学相关因素相似。
有必要投入研究以了解全球处方药物过量的不同决定因素。其他几个国家需要系统且持续地收集有关处方阿片类药物和其他处方药销售、处方药的非医疗使用以及因处方药过量导致的住院情况的数据。关于过量用药环境决定因素的证据稀少,这表明需要进行研究,为我们可用于预防药物过量的环境干预类型提供信息。未来研究的方法学问题包括加强对无意致命和非致命过量用药的数据收集方法,并收集关于用药史、用药来源(针对处方药)以及过量用药个体的人口统计学和精神病学病史特征的更详细信息。